The assessment of breathlessness in pulmonary arterial hypertension: Reliability and validity of the Dyspnoea-12

The assessment of breathlessness in pulmonary arterial hypertension: Reliability and validity of the Dyspnoea-12
复制标题

DOI:
10.1177/1474515113514891
复制
发表时间:
2014-12-01
影响因子:
2.9
通讯作者:
Armstrong, Iain
Armstrong, Iain
中科院分区:
医学2区
文献类型:
--
作者:
Yorke, Janelle;Armstrong, Iain

文献摘要

被引文献

相似文献

呼吸困难是肺动脉高压(PAH)的主要症状,但以前没有呼吸困难仪器已被测试的可靠性和有效性,这一人群。采用横断面设计,我们测试了呼吸困难-12(D-12)的心理测量学特性,用于评估PAH患者的呼吸困难。Pearson相关分析与世界卫生组织心功能分级(WHO FC)、明尼苏达心力衰竭-肺动脉高压生活量表(MLHF-PH)、医院焦虑抑郁量表(HADS)和6分钟步行距离试验(6 MWD)进行相关分析。参与者(n = 176)大多为女性(70.5%),平均年龄54.3 ± 14岁;诊断为特发性PAH(48.9%)、先天性心脏病(27.8%)和结缔组织病(23.3%);大多数为WHO FC II(32.4%)和III(52.3%)。D-12表现出良好的内部一致性的总得分和两个组成部分的身体和情绪(克朗巴赫的0.95,0.93和0.94,分别)。D-12总分与MLHF-PH(r = 0.70)、HADS(焦虑r = 0.54和抑郁r = 0.68)、WHO FC(r = 0.49)和6 MWD(r = -0.26)显著相关。在PAH患者中,D-12 -一种简短的患者报告的呼吸困难严重程度测量方法,利用了身体和情绪成分,是一种可靠有效的工具。
Breathlessness is a cardinal symptom of pulmonary arterial hypertension (PAH); yet no breathlessness instrument has been previously tested for reliability and validity for this population. Using a cross-sectional design, we tested the psychometric properties of the Dyspnoea-12 (D-12), for the assessment of breathlessness in PAH. Pearson's correlations with World Health Organization functional class (WHO FC), Minnesota Living with Heart failure - pulmonary hypertension modified version (MLHF-PH), Hospital Anxiety and Depression scale (HADS) and 6-minute walk distance test (6MWD) were conducted. Participants (n = 176) were mostly female (70.5%), mean age 54.3 +/- 14 years; diagnosed with idiopathic PAH (48.9%), congenital heart disease (27.8%) and connective tissue disease (23.3%); and most were WHO FC II (32.4%) and III (52.3%). The D-12 showed excellent internal consistency for the total and two-component scores for physical and emotional (Cronbach's 0.95, 0.93 and 0.94, respectively). D-12 total score was significantly associated with MLHF-PH (r = 0.70), HADS (anxiety r = 0.54 and depression r = 0.68), WHO FC (r = 0.49), and 6MWD (r = -0.26). In patients with PAH, the D-12 - a short patient reported measure of breathlessness severity that taps the physical and emotional components, is a reliable and valid instrument.